Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 UCB Outsources Med-Chem Program to BioFocus DPI | Contract Pharma

What are you searching for?

Sign in
Breaking News

UCB Outsources Med-Chem Program to BioFocus DPI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioFocus DPI, Galapagos’ service division, has signed a contract with UCB to supply chemistry services in the UK for one of UCB’s medicinal chemistry programs. The total contract value for Galapagos could potentially exceed $6 million. Galapagos is also eligible to receive as much as $749,000 in success-based payments.
    
UCB will transfer a team of chemists to BioFocus DPI from UCB’s recently closed Cambridge research site and BioFocus DPI will continue UCB’s chemistry work for the program towards candidate selection stage. Under the contract, UCB will provide biology support for the program.
   
“This agreement demonstrates BioFocus DPI’s flexibility in meeting client needs,” said Chris Newton, senior vice president of BioFocus DPI. “This innovative deal structure allows UCB to progress their program externally while applying the specific project expertise that UCB has already built internally.”
   
“UCB is delighted to be able to work with BioFocus DPI in this way, combining our expertise to advance this program towards development,” said Dr. Neil Weir, senior vice president research, UCB.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics